Revenue
$108m
-5.3% ↓ vs $114.1m
PBT swung 167.1% to $4.5m profit on lower interest and a tax credit, but EBITDA margin sat at the lower edge of MPG's historical range at 8.8%.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY26 vs HY25
Revenue
$108m
-5.3% ↓ vs $114.1m
EBITDA
$9.4m
+2.4% ↑ vs $9.2m
Net profit after tax
$2.9m
+158.0% ↑ vs −$5m
Net cash inflow from operating activities
$5.8m
+71.3% ↑ vs $3.4m
Operating profit
$9.5m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Profit before tax
$4.5m
+166.2% ↑ vs −$6.8m
Cash and cash equivalents
$5.4m
-42.0% ↓ vs $9.3m
Total assets
$199.8m
-8.0% ↓ vs $217.2m
What changed
A $23.9m equity raise and roughly $33.9m of debt repayment took net debt from $60.5m at March 2025 to $27.4m, dropping net debt/EBITDA to 2.9x against Annolyse's three-period historical range of 3.20x–6.00x and a 4.37x mean. Total equity rose 42.8% to $62.0m while gross borrowings fell 48.1% to $33.5m.
Trading was softer. Revenue fell 5.3% to $108.0m, within the historical range (-12.4% to +18.2%). EBITDA edged up 2.4% to $9.4m, but margin compressed to 8.8% – the lower edge of the three-period historical range that averages 10.6%. PBT swung 167.1% to $4.5m and NPAT 157.2% to $2.9m, both flattered by reductions in interest expense, the absence of prior-period significant items, and a tax credit producing an effective tax rate of -36.7% (against +25.7% in HY25).
What matters
Net debt has been cut more than in half through the recapitalisation, and 2.9x net debt/EBITDA is below the supplied historical baseline. This matters because MPG's prior-period commentary repeatedly described debt as too high for the cycle; the constraint has been materially loosened, which means future earnings flow more cleanly to equity holders even at a depressed EBITDA level.
Margins remain weak despite the headline profit swing. EBITDA margin of 8.8% is below the historical mean of 10.6%, gross margin slipped 115bps to 38.2%, and underlying EBITDA growth of 2.4% on a 5.3% revenue decline reflects cost discipline rather than demand recovery. The implication is that the swing from a $5.0m loss to a $2.9m profit is driven below the operating line, not at it.
Tax distortion inflates the bottom line. The -36.7% effective tax rate is classified as an unprecedented low against a four-period mean of 10.9%. PBT growth of 167.1% is the cleaner operating read; the 9.9pp gap between PBT and NPAT growth reflects the tax credit, which is unlikely to repeat and should not be extrapolated.
Expectations
Annolyse's second-half shape context shows HY25 carried 164.7% of FY25 EBITDA and 53.3% of FY25 revenue, implying an FY25 second half with negative EBITDA of -$3.6m and an NPAT loss of -$8.5m. That makes the half-on-half compare flattering and raises the question of whether the operating run-rate has genuinely stepped up or whether the second half will again drag.
The current annualised revenue run-rate of $216.0m is broadly consistent with FY25's $213.9m, so investors cannot yet read a top-line recovery from this print – only stabilisation alongside a much lighter capital structure.
Quality of result
Operating cash flow rose to $5.8m from $3.4m, capex held at 1.4% of revenue, and FCF pre-lease of $4.2m converted to 147.6% of NPAT. Cash conversion at 61.1% sits at the upper edge of the historical range (mean 43.2%), with debtor days (51.5) and inventory days (44.3) both within their historical ranges, so the cash result is not being lent by working capital.
Less durable are the bottom-line drivers. The PBT/NPAT swing is leaning on three transitory effects: a tax credit, lower interest expense (only partly structural now that debt is lower), and the non-repeat of prior-period significant items. Stripping the tax credit, NPAT would be materially smaller. The headline turnaround is real in direction but smaller in magnitude than the 157.2% NPAT growth suggests.
Unresolved
This briefing cannot assess whether the demand environment in MPG's end markets has stabilised or continues to deteriorate, as no forward order-book or guidance disclosures are supplied.
Chat
Ask follow-up questions about Metro Performance Glass's HY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
1. 1H26 results announcement
HY26 / results announcement2. MPG Interim Financial Statements FY26
HY26 / financial report1. 1H25 results announcement
HY25 / results announcement1. 1H25 results announcement
HY25 / results release2. MPG Interim report 1H25.pdf
HY25 / financial report1. MPG FY25 results announcement
FY25 / results announcement1. MPG FY25 results announcement
FY25 / results release3. MPG FY25 Annual Report
FY25 / financial reportMPG ASM Presentation
HY26 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 9.9pp, with a distortion flag in the result.
Cash conversion quality
This result converted 61.1% of EBITDA to operating cash flow, +24.5pp versus the prior comparable period.
ROE and capital efficiency
ROE was 4.6%, +16.2pp versus the prior comparable period.
Leverage and balance-sheet risk
Net debt / EBITDA is 2.90x, -3.10x versus the prior comparable period.
Get the next Metro Performance Glass briefing and related NZX reporting-season updates by email.